Insights

Target Life-Saving Demand ResQ Pharma focuses on lipid-based therapies for life-threatening conditions such as LAST, intraoperative hypotension, and non-opioid overdoses, creating a clear market need for life-saving, readily accessible treatments.

Regulatory Milestone Opportunity With a PDUFA date of June 2, 2025, there is a imminent regulatory milestone that can drive first-to-market advantage and expedited sales discussions with hospital systems and procurement teams.

Lean but Valuable Small team size (2-10 employees) may enable nimble, relationship-driven selling to specialty pharmacies, hospitals, and anesthesia providers, while signaling potential scale-up as revenue grows toward mid-market benchmarks.

Revenue Growth Path Current revenue is in the low seven-figure range with a capital raise of $2.3M, indicating a sales opportunity ramp as the product reaches market access, formulary inclusion, and payer coverage.

Competitive Positioning Operating in a space with major industry players as peers suggests strategic emphasis on differentiated lipid-based rescue therapy, potential for partnerships or channel collaboration to accelerate adoption and counter larger incumbents.

Similar companies to ResQ Pharma, Inc.

ResQ Pharma, Inc. Tech Stack

ResQ Pharma, Inc. uses 8 technology products and services including Amazon Web Services, gstatic.com, GoDaddy Website Builder, and more. Explore ResQ Pharma, Inc.'s tech stack below.

  • Cloud Hosting
  • gstatic.com
    Content Delivery Network
  • GoDaddy Website Builder
    Content Management System
  • Element UI
    Javascript Frameworks
  • PWA
    Miscellaneous
  • reCAPTCHA
    Security
  • Google Search Console
    Web Analytics
  • GoDaddy
    Web Hosting

ResQ Pharma, Inc.'s Email Address Formats

ResQ Pharma, Inc. uses at least 2 email formats:
ResQ Pharma, Inc. Email FormatsExamplePercentage
First@lipidrescue.comJohn@lipidrescue.com
67%
FirstL@lipidrescue.comJohnD@lipidrescue.com
33%

Frequently Asked Questions

What is ResQ Pharma, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
ResQ Pharma, Inc.'s official website is resqpharma.com and has social profiles on LinkedIn.

How much revenue does ResQ Pharma, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, ResQ Pharma, Inc.'s annual revenue is estimated to be $1M - $10M.

What is ResQ Pharma, Inc.'s NAICS code?

Minus sign iconPlus sign icon
ResQ Pharma, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ResQ Pharma, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, ResQ Pharma, Inc. has approximately 3 employees across 1 continents, including North America. Key team members include Chief Administrative Officer, General Counsel, Board Of Directors: J. S., Chief Operating Officer, Board Member: D. O. and Other: G. W. Explore ResQ Pharma, Inc.'s employee directory with LeadIQ.

What industry does ResQ Pharma, Inc. belong to?

Minus sign iconPlus sign icon
ResQ Pharma, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does ResQ Pharma, Inc. use?

Minus sign iconPlus sign icon
ResQ Pharma, Inc.'s tech stack includes Amazon Web Services, gstatic.com, GoDaddy Website Builder, Element UI, PWA, reCAPTCHA, Google Search Console and GoDaddy.

What is ResQ Pharma, Inc.'s email format?

Minus sign iconPlus sign icon
ResQ Pharma, Inc.'s email format typically follows the pattern of First@lipidrescue.com. Find more ResQ Pharma, Inc. email formats with LeadIQ.

How much funding has ResQ Pharma, Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2026, ResQ Pharma, Inc. has raised $2.3M in funding. The last funding round occurred on Jun 16, 2022 for $206K.

When was ResQ Pharma, Inc. founded?

Minus sign iconPlus sign icon
ResQ Pharma, Inc. was founded in 2015.
ResQ Pharma, Inc. logo

ResQ Pharma, Inc.

Pharmaceutical ManufacturingIllinois, United States2-10 Employees

ResQ Pharma, Inc. is a specialty pharmaceutical company based in Glenview, Illinois, focused on ensuring reliable access to life-saving lipid-based therapies, exemplified by LipidRescue™, to address critical conditions such as local anesthetic systemic toxicity, cardiac instability from intraoperative hypotension, and non-opioid overdoses. The company targets medical settings where rapid, effective intervention is essential, aiming to provide solutions for life-threatening indications and improve patient outcomes in urgent care scenarios. Operating within the pharmaceutical manufacturing industry, ResQ Pharma positions itself as a provider of essential lipid-based therapies designed to treat severe toxicities with a focus on dependable availability. The organization is small in scale, and its stated near-term milestone includes a regulatory date in mid-2025, signaling a planned product introduction that could begin generating activity in 2025. } } }** Wait: I included a stray closing braces; need correct JSON. Also ensure no marketing tone. Should avoid mentions of revenue as requested. The description mentions PDUFA date June 2, 2025; that's a concrete development. Ensure 2-6 sentences. Let's craft properly. Also ensure valid JSON. Let's produce: 4-5 sentences. Let's rewrite. Provide no extra braces. Let's output: {

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2015
Employees
2-10

Section iconFunding & Financials

  • $2.3M

    ResQ Pharma, Inc. has raised a total of $2.3M of funding over 4 rounds. Their latest funding round was raised on Jun 16, 2022 in the amount of $206K as a Venture Round.

  • $1M - $10M

    ResQ Pharma, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.